WASHINGTON — What would President Trump’s nearly 20-percent cut to the National Institutes of Health’s budget actually look like? Every one of the dozen-plus research areas the agency funds would likely take a hit — and the actual consequences for medical research could be even worse than they look on paper.

Advocates for medical research would expect blanket cuts across NIH — from cancer and Alzheimer’s disease to drug addiction and environmental health — if Congress were to approve the $5.8 billion cut that Trump has proposed. Each institute would be looking at its own reduction, upward of 20 percent for the next spending year.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy